Breast reconstruction involves surgical procedures that recreate a natural-looking breast shape and form for women who have undergone mastectomy or breast surgery to treat cancer and other conditions. There are various breast reconstruction procedures available that use either tissue from another part of the patient’s body, known as autologous reconstruction or implants to restore breast shape. The global breast reconstruction market offers a variety of prosthetic products like tissue expanders, breast implants and acellular dermal matrix to match breast sizes and types for improved aesthetic outcomes. With increasing awareness about reconstruction options after mastectomy, more women are opting for prosthetic reconstruction that allows complete or partial breast restoration.
The global Breast Reconstruction market is estimated to be valued at US$2.38 Billion in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Advanced 3D printing technologies are finding increasing applications in breast reconstruction surgeries. 3D printed models created from patients’ CT or MRI scans help surgeons preoperatively plan intricate breast reconstruction procedures. 3D printed, custom-made, bioresorbable internal breast implants are being researched that can potentially improve cosmetic outcomes and reduce revision surgeries. As 3D printing technologies mature, they are expected to transform breast reconstruction strategies over the next decade.
Threat of new entrants: The threat of new entrants in the breast reconstruction market is moderate as it requires substantial investment and regulatory approvals to launch new products.
Bargaining power of buyers: The bargaining power of buyers is low to moderate as the market is fragmented with several players operating in the market providing multiple options to buyers.
Bargaining power of suppliers: The bargaining power of suppliers is low as there are multiple suppliers for raw materials in the market.
Threat of new substitutes: The threat of new substitutes is low as there are limited treatment options available for breast reconstruction.
Competitive rivalry: The competitive rivalry in the market is high owing to the presence of major players operating globally.
The global breast reconstruction market is expected to witness high growth over the forecast period. The global Breast Reconstruction market is estimated to be valued at US$2.38 Billion in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 to 2031.
North America is expected to dominate the global market over the forecast period owing to the rising prevalence of breast cancer and increasing awareness regarding breast reconstruction procedures in the region.
Key players operating in the breast reconstruction market are Allergan Plc, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics Plc, POLYTECH Health & Aesthetics GmbH, Hansbiomed Co. Ltd., ide m dicus Co. Ltd., Guangzhou Wanhe Plastic Materials Co. Ltd.
*Note:1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it